. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
of all car-t cell trials registered since 2001, more than half are being conducted in china.
., looking for billing codes to identify emergency room visits, observation stays, and inpatient hospitalizations
.
.